Fadi Al-Khayer, MD
Endocrinology, Diabetes & Metabolism · Storrs, CTNPI 1861477069
Payments from drug & device makers
Across 713 payments — averaging $685.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$144K
- Corcept Therapeutics$143K
- Novo Nordisk$124K
- AstraZeneca$56K
- Johnson & Johnson$16K
- AbbVie$5K
- plus $731 from 12 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 291 | $144,476 |
| Corcept Therapeutics | 174 | $142,708 |
| Novo Nordisk | 115 | $124,403 |
| AstraZeneca(2 entities) | 75 | $55,843 |
| Johnson & Johnson | 18 | $15,690 |
| AbbVie | 18 | $5,137 |
| Xeris Pharmaceuticals, Inc. | 8 | $332 |
| Kyowa Kirin, Inc. | 1 | $125 |
| Amgen | 3 | $58 |
| Abbott | 2 | $34 |
| Lexicon Pharmaceuticals, Inc. | 1 | $29 |
| Insulet Corporation | 1 | $27 |
| Almatica Pharma LLC | 1 | $26 |
| Senseonics, Incorporated | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Intra-sana Laboratories | 1 | $21 |
| Recordati_rare_diseases_inc. | 1 | $17 |
| Bayer | 1 | $17 |
How this compares
$488,989 in reported general payments places this provider in the 95th percentile of 177 endocrinology, diabetes & metabolism providers in Connecticut.
See all endocrinology, diabetes & metabolism providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Storrs
- Ania JastreboffNew Haven$2.2M
- Ilja HulinskyBridgeport$1.6M
- Gerald ShulmanNew Haven$1M
- Karl InsognaNew Haven$903K
- Clemens BergwitzNew Haven$735K
- Egils BogdanovicsTorrington$608K
- Robert ObersteinHartford$516K
- Silvio InzucchiNew Haven$461K
- Francis WilsonNew Haven$415K
- Philip GoldbergNew Haven$324K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.